跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
XYLOCAINE 4% TOPICAL liqnocaine hydrochloride 40mg/mL solution bottle (reformulation) - TGA Drug Approval Details
Approvals
/
TGA
/
XYLOCAINE 4% TOPICAL liqnocaine hydrochloride 40mg/mL solution bottle (reformulation)
Approved
STANDARD
XYLOCAINE 4% TOPICAL liqnocaine hydrochloride 40mg/mL solution bottle (reformulation)
Aspen Pharmacare Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
ccc1073e3eaab31c
Company
Aspen Pharmacare Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
ccc1073e3eaab31c
Product Name
XYLOCAINE 4% TOPICAL liqnocaine hydrochloride 40mg/mL solution bottle (reformulation)
Artg Id
124858
Artg Name
XYLOCAINE 4% TOPICAL liqnocaine hydrochloride 40mg/mL solution bottle (reformulation)
Sponsor
Aspen Pharmacare Australia Pty Ltd
Company Detail Path
/organization/aspen-pharmacare-australia-pty-ltd
Artg Date
2006-01-10
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
ccc1073e3eaab31c
Type
Standard
Back to TGA Approvals
